Updated:
Microbiologics
Microbiologics is a other based in Saint Cloud, founded 1971; the Altss profile covers its classification, headquarters, registration, AUM band, and key...
Microbiologics
Leading providers of biomaterials, anti-infective testing, assay development and CRO services for microbiology, molecular diagnostics and virology
General information
Firm type
other
Year founded
1971
Location
Region
North America
Country
United States
City
Saint Cloud
Corporate office
Saint Cloud, MN, United States
Additional offices
Kalamazoo, MI · Lexington, KY · San Diego, CA
Sector focus
Frequently asked questions
What products does Microbiologics offer?
Microbiologics offers a range of biological reference materials for microbiology QC, including KWIK-STIK, EZ-Accu Shot, Epower, and Helix Elite molecular standards. The company also provides custom microbial controls, proficiency solutions, and contract research services for antimicrobial and antiviral testing.
Does Microbiologics serve clinical laboratories or only research facilities?
The company serves both. Its website lists clinical diagnostics as one industry vertical, alongside pharmaceuticals, food safety, and water/environmental testing. Molecular diagnostic products include external quality controls for IVD instruments used in clinical labs.
What is Microbiologics' role in virology research?
Microbiologics operates BSL-2 and BSL-3 laboratories for custom viral stock production, antiviral assay development, and vaccine testing. Services include off-the-shelf and recombinant virus stocks, as well as viral assay development for product release testing.
Where are Microbiologics' facilities located?
The company operates five US locations: its headquarters in Saint Cloud, Minnesota, plus sites in Kalamazoo (Michigan), Lexington (Kentucky), and San Diego (California). These centers support microbiology R&D, molecular diagnostics, and virology services.
Has Microbiologics announced any recent acquisitions or expansions?
The company's website lists several news items including an acquisition of SensID to expand diagnostic quality controls, additional BSL-3 laboratory capacity, appointment of a new CEO, and expansion of virology services. No dates or financial terms are provided in the available source material.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: